Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Psychopharmacology|January 1, 1981
High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteersR Raisman, D Sechter, M S Briley, et al.
Science (New York, N.Y.)|July 11, 1980
Tritiated imipramine binding sites are decreased in platelets of untreated depressed patientsM S Briley, S Z Langer, R Raisman, et al.
Psychopharmacology|January 1, 1982
3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteersR Raisman, M S Briley, F Bouchami, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 3, 2014
Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatment-resistant depression treated with escitalopramD Bennabi, M Nicolier, J Monnin, et al.
Journal of Receptor Research|January 1, 1987
Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depressionS Z Langer, A M Galzin, M F Poirier, et al.
Revue Neurologique|March 20, 2016
Slowing of information processing speed without motor slowing in multiple sclerosis observed during two crossing-off tasksM Binétruy, G Chopard, E Laurent, et al.
Revue Neurologique|April 9, 2011
[Diagnostic norms of RAPID neuropsychological battery tests for subjects aged 60 to 89 years with Alzheimer's disease]G Sylvestre, G Chopard, G Tio, et al.
Pharmacological Research|June 1, 1995
Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patientsS Vandel, G Bertschy, P Baumann, et al.
Neuropsychobiology|January 1, 1992
Tricyclic antidepressant plasma levels after fluoxetine additionS Vandel, G Bertschy, B Bonin, et al.
Psychopharmacology|January 1, 1986
Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitorsM F Poirier, C Benkelfat, H Loo, et al.
Pageof 8